Credit Suisse’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-19,408
| Closed | -$72K | – | 3624 |
|
|
2017
Q4 | $72K | Sell |
19,408
-3,980
| -17% | -$14.8K | ﹤0.01% | 3380 |
|
|
2017
Q3 | $95K | Buy |
+23,388
| New | +$95K | ﹤0.01% | 3616 |
|
|
2017
Q2 | – | Sell |
-10,650
| Closed | -$44K | – | 3552 |
|
|
2017
Q1 | $44K | Buy |
+10,650
| New | +$44K | ﹤0.01% | 3379 |
|
|
2016
Q4 | – | Sell |
-4,816
| Closed | -$47K | – | 3863 |
|
|
2016
Q3 | $47K | Sell |
4,816
-56,306
| -92% | -$549K | ﹤0.01% | 3682 |
|
|
2016
Q2 | $345K | Buy |
61,122
+57,034
| +1,395% | +$322K | ﹤0.01% | 3330 |
|
|
2016
Q1 | $31K | Sell |
4,088
-7,525
| -65% | -$57.1K | ﹤0.01% | 3620 |
|
|
2015
Q4 | $155K | Buy |
11,613
+5,920
| +104% | +$79K | ﹤0.01% | 3757 |
|
|
2015
Q3 | $94K | Sell |
5,693
-5,689
| -50% | -$93.9K | ﹤0.01% | 3889 |
|
|
2015
Q2 | $255K | Buy |
11,382
+5,669
| +99% | +$127K | ﹤0.01% | 3808 |
|
|
2015
Q1 | $56K | Sell |
5,713
-5,659
| -50% | -$55.5K | ﹤0.01% | 3990 |
|
|
2014
Q4 | $129K | Buy |
11,372
+8,419
| +285% | +$95.5K | ﹤0.01% | 4008 |
|
|
2014
Q3 | $34K | Sell |
2,953
-5,081
| -63% | -$58.5K | ﹤0.01% | 3971 |
|
|
2014
Q2 | $156K | Sell |
8,034
-40,265
| -83% | -$782K | ﹤0.01% | 4018 |
|
|
2014
Q1 | $866K | Buy |
48,299
+37,445
| +345% | +$671K | ﹤0.01% | 2904 |
|
|
2013
Q4 | $115K | Buy |
+10,854
| New | +$115K | ﹤0.01% | 3997 |
|
|
2013
Q3 | – | Sell |
-26,560
| Closed | -$250K | – | 3936 |
|
|
2013
Q2 | $250K | Buy |
+26,560
| New | +$250K | ﹤0.01% | 3348 |
|